Flavonoid chrysin activates both TrkB and FGFR1 receptors while upregulates their endogenous ligands such as brain derived neurotrophic factor to promote human neurogenesis

Abstract

Neurogenesis is the process of generating new neurons from neural stem cells (NSCs) and plays a crucial role in neurological diseases. The process involves a series of steps, including NSC proliferation, migration and differentiation, which are regulated by multiple pathways such as neurotrophic Trk and fibroblast growth factor receptors (FGFR) signalling. Despite the discovery of numerous compounds capable of modulating individual stages of neurogenesis, it remains challenging to identify an agent that can regulate multiple cellular processes of neurogenesis. Here, through screening of bioactive compounds in dietary functional foods, we identified a flavonoid chrysin that not only enhanced the human NSCs proliferation but also facilitated neuronal differentiation and neurite outgrowth. Further mechanistic study revealed the effect of chrysin was attenuated by inhibition of neurotrophic tropomyosin receptor kinase-B (TrkB) receptor. Consistently, chrysin activated TrkB and downstream ERK1/2 and AKT. Intriguingly, we found that the effect of chrysin was also reduced by FGFR1 blockade. Moreover, extended treatment of chrysin enhanced levels of brain-derived neurotrophic factor, as well as FGF1 and FGF8. Finally, chrysin was found to promote neurogenesis in human cerebral organoids by increasing the organoid expansion and folding, which was also mediated by TrkB and FGFR1 signalling. To conclude, our study indicates that activating both TrkB and FGFR1 signalling could be a promising avenue for therapeutic interventions in neurological diseases, and chrysin appears to be a potential candidate for the development of such treatments.

References

[1] BondAM, MingGL, SongH. Adult mammalian neural stem cells and neurogenesis: five decades later. Cell Stem Cell. 2015;17(4):385-395.

[2] Leal-GaliciaP, Chávez-Hernández ME, MataF, et al. Adult neurogenesis: a story ranging from controversial new neurogenic areas and human adult neurogenesis to molecular regulation. Int J Mol Sci. 2021;22(21):11489.

[3] GonçalvesJT, Schafer ST, GageFH. Adult neurogenesis in the hippocampus: from stem cells to behavior. Cell. 2016;167(4):897-914.

[4] ObernierK, Cebrian-Silla A, ThomsonM, et al. Adult neurogenesis is sustained by symmetric self-renewal and differentiation. Cell Stem Cell. 2018;22(2):221-234.e228.

[5] XuM, GuoY, WangM, et al. L-arginine homeostasis governs adult neural stem cell activation by modulating energy metabolism in vivo. EMBO J. 2023;42(6):e112647.

[6] Montalbán-LoroR, Lassi G, Lozano-UreñaA, et al. Dlk1 dosage regulates hippocampal neurogenesis and cognition. Proc Natl Acad Sci U S A. 2021;118(11):e2015505118.

[7] ZalouliV, Rajavand H, BayatM, et al. Adult hippocampal neurogenesis (AHN) controls central nervous system and promotes peripheral nervous system regeneration via physical exercise. Biomed Pharmacother. 2023;165:115078.

[8] MathewsKJ, AllenKM, BoerrigterD, Ball H, Shannon WeickertC, DoubleKL. Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers. Aging Cell. 2017;16(5):1195-1199.

[9] ZhaoX, FisherES, WangY, Zuloaga K, ManleyL, TempleS. 4D imaging analysis of the aging mouse neural stem cell niche reveals a dramatic loss of progenitor cell dynamism regulated by the RHO-ROCK pathway. Stem Cell Rep. 2022;17:245-258.

[10] KimJY, ChoiK, ShakerMR, et al. Promotion of cortical neurogenesis from the neural stem cells in the adult mouse subcallosal zone. Stem Cells. 2016;34(4):888-901.

[11] MingGL, SongH. Adult neurogenesis in the mammalian brain: significant answers and significant questions. Neuron. 2011;70(4):687-702.

[12] BaptistaP, Andrade JP. Adult hippocampal neurogenesis: regulation and possible functional and clinical correlates. Front Neuroanat. 2018;12:44.

[13] SanyalS, Sandstrom DJ, HoefferCA, RamaswamiM. AP-1 functions upstream of CREB to control synaptic plasticity in drosophila. Nature. 2002;416(6883):870-874.

[14] MahlerJ, Filippi A, DrieverW. DeltaA/DeltaD regulate multiple and temporally distinct phases of notch signaling during dopaminergic neurogenesis in zebrafish. J Neurosci. 2010;30(49):16621-16635.

[15] WangCS, Kavalali ET, MonteggiaLM. BDNF signaling in context: from synaptic regulation to psychiatric disorders. Cell. 2022;185(1):62-76.

[16] LiuC, ChanCB, YeK. 7, 8-Dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders. Transl Neurodegener. 2016;5:2.

[17] LuoD, ShiY, WangJ, et al. 7, 8-Dihydroxyflavone protects 6-OHDA and MPTP induced dopaminergic neurons degeneration through activation of TrkB in rodents. Neurosci Lett. 2016;620:43-49.

[18] NumakawaT, OdakaH. The role of neurotrophin signaling in age-related cognitive decline and cognitive diseases. Int J Mol Sci. 2022;23(14):7726.

[19] XieY, SuN, YangJ, et al. FGF/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5(1):181.

[20] YangF, WhelanEC, GuanX, et al. FGF9 promotes mouse spermatogonial stem cell proliferation mediated by p38 MAPK signalling. Cell Prolif. 2021;54(1):e12933.

[21] MudòG, BonomoA, Di LibertoV, Frinchi M, FuxeK, BelluardoN. The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain. J Neural Transm. 2009;116(8):995-1005.

[22] AlshammariMA, Alshammari TK, NenovMN, ScalaF, LaezzaF. Fibroblast growth factor 14 modulates the neurogenesis of granule neurons in the adult dentate gyrus. Mol Neurobiol. 2016;53(10):7254-7270.

[23] TurnerCA, AkilH, WatsonSJ, Evans SJ. The fibroblast growth factor system and mood disorders. Biol Psychiatry. 2006;59(12):1128-1135.

[24] IwataT, HevnerRF. Fibroblast growth factor signaling in development of the cerebral cortex. Dev Growth Differ. 2009;51(3):299-323.

[25] Grońska-PęskiM, MowreyW, Hébert JM. FGFR regulation of dendrite elaboration in adult-born granule cells depends on intracellular mediator and proximity to the Soma. Neuroscience. 2021;453:148-167.

[26] FarrellB, BreezeAL. Structure, activation and dysregulation of fibroblast growth factor receptor kinases: perspectives for clinical targeting. Biochem Soc Trans. 2018;46(6):1753-1770.

[27] RageF, SilholM, BinameF, Arancibia S, Tapia-ArancibiaL. Effect of aging on the expression of BDNF and TrkB isoforms in rat pituitary. Neurobiol Aging. 2007;28(7):1088-1098.

[28] QinX, ZhaoY, ZhangT, et al. TrkB agonist antibody ameliorates fertility deficits in aged and cyclophosphamide-induced premature ovarian failure model mice. Nat Commun. 2022;13(1):914.

[29] DittrichF, OchsG, Grosse-WildeA, et al. Pharmacokinetics of intrathecally applied BDNF and effects on spinal motoneurons. Exp Neurol. 1996;141(2):225-239.

[30] PouloseSM, MillerMG, ScottT, Shukitt-Hale B. Nutritional factors affecting adult neurogenesis and cognitive function. Adv Nutr. 2017;8(6):804-811.

[31] ValeroJ, ParisI, SierraA. Lifestyle shapes the dialogue between environment, microglia, and adult neurogenesis. ACS Chem Nerosci. 2016;7(4):442-453.

[32] KumarS, PandeyAK. Chemistry and biological activities of flavonoids: an overview. Sci World J. 2013;2013:162750.

[33] CichonN, Saluk-Bijak J, GorniakL, PrzysloL, BijakM. Flavonoids as a natural enhancer of neuroplasticity-an overview of the mechanism of neurorestorative action. Antioxidants. 2020;9(11):1035.

[34] NurkE, RefsumH, DrevonCA, et al. Intake of flavonoid-rich wine, tea, and chocolate by elderly men and women is associated with better cognitive test performance. J Nutr. 2009;139(1):120-127.

[35] AlmullaAYH, Mogulkoc R, BaltaciAK, DasdelenD. Learning, neurogenesis and effects of flavonoids on learning. Mini Rev Med Chem. 2022;22(2):355-364.

[36] CalisZ, Mogulkoc R, BaltaciAK. The roles of flavonols/flavonoids in neurodegeneration and neuroinflammation. Mini Rev Med Chem. 2020;20(15):1475-1488.

[37] CuiZ, ZhaoX, AmevorFK, et al. Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism. Front Immunol. 2022;13:943321.

[38] DongX, ChenY, LuJ, HuangS, PeiG. β-Arrestin 2 and Epac2 cooperatively mediate DRD1-stimulated proliferation of human neural stem cells and growth of human cerebral organoids. Stem Cells. 2022;40(9):857-869.

[39] SonoyamaT, Stadler LKJ, ZhuM, et al. Human BDNF/TrkB variants impair hippocampal synaptogenesis and associate with neurobehavioural abnormalities. Sci Rep. 2020;10(1):9028.

[40] LiY, Luikart BW, BirnbaumS, et al. TrkB regulates hippocampal neurogenesis and governs sensitivity to antidepressive treatment. Neuron. 2008;59(3):399-412.

[41] GuoW, Nagappan G, LuB. Differential effects of transient and sustained activation of BDNF-TrkB signaling. Dev Neurobiol. 2018;78(7):647-659.

[42] WangL, LiXX, ChenX, Qin XY, KardamiE, ChengY. Antidepressant-like effects of low-and high-molecular weight FGF-2 on chronic unpredictable mild stress mice. Front Mol Neurosci. 2018;11:377.

[43] HossainMS, OomuraY, KatafuchiT. Glucose can epigenetically alter the gene expression of neurotrophic factors in the murine brain cells. Mol Neurobiol. 2018;55(4):3408-3425.

[44] ChoyC, AnsariKI, NemanJ, et al. Cooperation of neurotrophin receptor TrkB and Her2 in breast cancer cells facilitates brain metastases. Breast Cancer Res. 2017;19(1):51.

[45] FukuyamaY, KuboM, HaradaK. Neurotrophic natural products. Prog Chem Org Nat Prod. 2024;123:1-473.

[46] SirichoatA, AnosriT, KaewngamS, et al. Neuroprotective properties of chrysin on decreases of cell proliferation, immature neurons and neuronal cell survival in the hippocampal dentate gyrus associated with cognition induced by methotrexate. Neurotoxicology. 2022;92:15-24.

[47] PrajitR, Sritawan N, SuwannakotK, et al. Chrysin protects against memory and hippocampal neurogenesis depletion in D-galactose-induced aging in rats. Nutrients. 2020;12(4):1100.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.